Notably, PARP2, one of the poly (ADP-ribose) polymerases, was upregulated in samples with low T cell infiltration (Figure 3E), giving us a hint that PARP inhibitors like Olaparib might be used as one of the potential drugs for Low cluster HCC. Here, PARP2 is linked to hepatocellular carcinoma.